Stocks of Novo Nordisk, Eli Lilly, and Viking Therapeutics rose premarket due to a proposed rule allowing Medicare to cover new obesity and diabetes drugs. This may lead to conflict between the pharmaceutical industry and Robert F. Kennedy Jr.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing